Teleflex Inc is a global provider of medical technology products that enhance the ability of healthcare professionals to provide high-quality patient care. The company develops a wide range of innovative solutions across various medical specialties, including surgical, critical care, and respiratory applications. Teleflex focuses on the design, manufacturing, and commercialization of devices and instruments that improve procedural outcomes, facilitate patient recovery, and enhance safety in both hospital and outpatient settings. With a commitment to advancing medical technologies, Teleflex aims to meet the evolving needs of healthcare providers and patients worldwide. Read More
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - specialty industry, including Teleflex (NYSE:TFX) and its peers.
December 9, 2025 – Teleflex Incorporated (NYSE: TFX) shares surged significantly today, marking it as a top market mover, following the announcement of a monumental strategic pivot. The medical technology company revealed definitive agreements to divest its Acute Care, Interventional Urology, and OEM (Original Equipment Manufacturer) businesses for a combined cash
Shares of medical technology company Teleflex (NYSE:TFX)
jumped 11.1% in the afternoon session after the company announced it agreed to sell its Acute Care, Interventional Urology, and OEM businesses for a combined total of $2.03 billion in cash. Teleflex stated it planned to use approximately $1.8 billion in net proceeds to pay down debt and return a significant amount of capital to its shareholders. In line with this strategy, the company's Board of Directors authorized a new share repurchase program for up to $1 billion of its common stock. This move was intended to allow Teleflex to focus on its core businesses, including Vascular Access, Interventional, and Surgical. The market viewed the divestiture and the commitment to shareholder returns as a positive development.
A company that generates cash isn’t automatically a winner.
Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Teleflex (TFX) stock appears deeply undervalued with a low P/E ratio, strong profitability, and solid financial health, making it a compelling pick for value investors.
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally. Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to markets amid concerns over high valuations, particularly in AI-related stocks.
WAYNE, Pa., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE: TFX) is scheduled to speak at the Jefferies Global Healthcare Conference in London on Tuesday, November 18, 2025, at 10:00 a.m. (GMT).
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor.
The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
Over the last six months, Teleflex’s shares have sunk to $111.34, producing a disappointing 12.2% loss - a stark contrast to the S&P 500’s 16.4% gain. This may have investors wondering how to approach the situation.
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around.
Without a clear path to profitability, these businesses risk running out of capital or relying on dilutive fundraising.
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns.
Shares of medical technology company Teleflex (NYSE:TFX)
fell 15.5% in the morning session after the company reported underwhelming earnings. The medical technology firm's operating margin collapsed to negative 44.8%, a stark reversal from the positive 19.5% margin recorded in the same quarter a year ago. This dramatic 64.3 percentage point drop indicated that the company’s expenses grew much faster than its revenue. Adding to the concerns, Teleflex's cash generation also weakened significantly, with its free cash flow margin falling to 8.5% from 27.5% in the prior year's quarter. While the company beat headline estimates and reiterated its full-year adjusted earnings guidance, the sharp decline in underlying profitability and cash flow appears to have alarmed investors, prompting a major sell-off.
Medical technology company Teleflex (NYSE:TFX) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 19.4% year on year to $913 million. Its non-GAAP profit of $3.67 per share was 8.6% above analysts’ consensus estimates.
WAYNE, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable December 15, 2025, to shareholders of record at the close of business on November 14, 2025.
WAYNE, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended September 28, 2025.
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
Discover Teleflex Inc (TFX), an undervalued stock with strong financials, solid profitability, and a low P/E ratio, offering a potential margin of safety for value investors.
WAYNE, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, November 6, 2025.
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.
Shares of medical technology company Teleflex (NYSE:TFX)
fell 5.4% in the afternoon session after the U.S. government launched a probe into the medical device industry.
